URAPIDIL KALCEKS 50 mg/10 ml, solution for injection/for infusion 5 ampoules of 10 ml
Active ingredients: Urapidil
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion5 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- URAPIDIL KALCEKS 50 mg/10 mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- AS KALCEKS (LETTONIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60111553CIP73022439CIP133400930224397Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| URAPIDILsolution | 50 mg · une ampoule de 10 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.